ArticleBMC gastroenterology2021

Clinical outcomes of doxorubicin-eluting CalliSpheres® beads-transarterial chemoembolization for unresectable or recurrent esophageal carcinoma.

Yonghua Bi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.